Evidence map›Paper›PMID 42129450›Full record

ArticleScientific reports2026

Synergistic effect of rare-earth and transition metal conversion coatings on bioactive hydroxyapatite mineralization and electrochemical behavior of AZ31 magnesium alloys.

Negin Nojoomi, Maryam Nikpayam, Helia Heydarinasab, Sahar Amiri, Hossein Eivaz Mohammadloo

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Negin NojoomiIran Polymer and Petrochemical Institute, Tehran, Iran.
Maryam NikpayamChemistry Department, Oregon State University, Corvallis, USA.
Helia HeydarinasabDepartment of Polymer Engineering and Color Technology, Amirkabir University of Technology, Tehran, Iran.
Sahar AmiriDepartment of Chemical Engineering, Science and Research Branch, Islamic Azad University, Tehran, Iran.
Hossein Eivaz MohammadlooIran Polymer and Petrochemical Institute, Tehran, Iran. h.mohammadloo@ippi.ac.ir.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cerium-vanadium conversion coatings were investigated as pretreatment layers to improve hydroxyapatite (HA) deposition on AZ31 magnesium alloy for enhanced corrosion protection and in-vitro bioactivity. Cerium-only (CeCC), vanadium-only (VCC), and a mixed Ce/V conversion coating (CeVCC) were prepared, and the optimized mixed conversion layer was subsequently used as the pretreatment for HA deposition to form a CeVCC + HA hybrid coating. Surface morphology and elemental composition were characterized by SEM/EDS, while wettability and surface functional groups were evaluated using static water contact-angle measurements and ATR-FTIR, respectively. Corrosion behavior in simulated body fluid (SBF) was assessed by electrochemical impedance spectroscopy (EIS) during prolonged immersion, complemented by hydrogen evolution measurements as kinetic indicators of Mg degradation. The CeVCC pretreatment produced a more compact and uniform surface and promoted homogeneous HA growth with improved interfacial integrity. Compared with bare AZ31 and single-layer coatings, the CeVCC + HA hybrid exhibited a higher impedance response and lower hydrogen evolution, indicating a markedly lower corrosion rate, while retaining Ca-P surface characteristics associated with bioactive behavior in SBF. These results demonstrate that Ce/V conversion pretreatment is an effective strategy for stabilizing HA coatings on Mg alloys and improving their performance in physiological environments.

Indexed as

Corrosion resistanceHydroxyapatiteImplantSimulated body fluid (SBF)Vanadium conversion coating

Identifiers

PMID42129450
PMCPMC13357835

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.